Author
Listed:
- Ashwini Hinge
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
- Juying Xu
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
- Jose Javier
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
- Eucabeth Mose
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
- Sachin Kumar
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
- Reuben Kapur
(Indiana University School of Medicine)
- Edward F. Srour
(Indiana University School of Medicine)
- Punam Malik
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
- Bruce J. Aronow
(Cincinnati Children’s Research Foundation, University of Cincinnati College of Medicine)
- Marie-Dominique Filippi
(Cincinnati Children's Research Foundation, University of Cincinnati College of Medicine)
Abstract
The mechanisms regulating hematopoietic stem and progenitor cell (HSPC) fate choices remain ill-defined. Here, we show that a signalling network of p190-B RhoGAP-ROS-TGF-β-p38MAPK balances HSPC self-renewal and differentiation. Upon transplantation, HSPCs express high amounts of bioactive TGF-β1 protein, which is associated with high levels of p38MAPK activity and loss of HSC self-renewal in vivo. Elevated levels of bioactive TGF-β1 are associated with asymmetric fate choice in vitro in single HSPCs via p38MAPK activity and this is correlated with the asymmetric distribution of activated p38MAPK. In contrast, loss of p190-B, a RhoGTPase inhibitor, normalizes TGF-β levels and p38MAPK activity in HSPCs and is correlated with increased HSC self-renewal in vivo. Loss of p190-B also promotes symmetric retention of multi-lineage capacity in single HSPC myeloid cell cultures, further suggesting a link between p190-B-RhoGAP and non-canonical TGF-β signalling in HSPC differentiation. Thus, intracellular cytokine signalling may serve as ‘fate determinants’ used by HSPCs to modulate their activity.
Suggested Citation
Ashwini Hinge & Juying Xu & Jose Javier & Eucabeth Mose & Sachin Kumar & Reuben Kapur & Edward F. Srour & Punam Malik & Bruce J. Aronow & Marie-Dominique Filippi, 2017.
"p190-B RhoGAP and intracellular cytokine signals balance hematopoietic stem and progenitor cell self-renewal and differentiation,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14382
DOI: 10.1038/ncomms14382
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14382. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.